Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen

Analys

Optomed: Partnership with Aireen and AI integration approval for Lumo - Redeye

{newsItem.title}

Redeye is positive about Optomed’s partnership with Aireen and the EU approval for AI integration with the Lumo camera. As previously stated, we see solid potential in Lumo and believe it can become an important growth driver for Optomed. The partnership and approval represent a step in that direction, and we reiterate our valuation of the company.

Länk till analysen i sin helhet: https://www.redeye.se/research/1144658/optomed-partnership-with-aireen-and-ai-integration-approval-for-lumo?utm_source=finwire&utm_medium=RSS

Nyheter om Optomed

Läses av andra just nu

Om aktien Optomed

Senaste nytt